Max Sinus tumours

119
NEOPLASM OF MAXILLARY SINUS

Transcript of Max Sinus tumours

Page 1: Max Sinus tumours

NEOPLASM OF MAXILLARY SINUS

Page 2: Max Sinus tumours

Definitions Neoplasm(willis)- abnormal mass of tissue, the

growth of which exceeds & uncoordinated with that of normal tissue & persists in same manner after cessation of stimuli which evokes the change.

Tumour- a mass of tissue formed as a result of abnormal, excessive, uncoordinated, autonomous, purposeless proliferation of cells

Page 3: Max Sinus tumours

TNM classification TNM classification 1,2 TNM classification of carcinomas of the nasal cavity and sinuses T – Primary tumour TX Primary tumour cannot be assessed T0 No evidence of primary tumour Tis Carcinoma in situ

Maxillary sinus T1- Tumour limited to the antral mucosa with no erosion or destruction of bone

T2- Tumour causing bone erosion or destruction, including extension into hard palate and/or middle nasal meatus, except extension to posterior antral

wall of maxillary sinus and pterygoid plates T3- Tumour invades any of the following: bone of posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses

Page 4: Max Sinus tumours

T4a- Tumour invades any of the following: anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses

T4b- Tumour invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve V2, nasopharynx, clivus

Page 5: Max Sinus tumours

N – Regional lymph nodes 3 NX: Regional lymph nodes cannot be

assessed N0: No regional lymph node metastasis N1: Metastasis in a single ipsilateral lymph

node, 3 cm or less in greatest dimension

Page 6: Max Sinus tumours

N2 Metastasis as specified in N2a, 2b, 2c below N2a: Metastasis in a single ipsilateral lymph node,

more than 3 cm but not more than 6 cm in greatest dimension

N2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension

N2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension

N3: Metastasis in a lymph node more than 6 cm in greatest dimension

Page 7: Max Sinus tumours

M – Distant metastasis MX Distant metastasis cannot be assessed M0 No distant metastasis M1 Distant metastasis

Page 8: Max Sinus tumours

Stage grouping Stage 0 Tis N0 M0 Stage I T1 N0 M0 Stage II T2 N0 M0 Stage III T1, T2 N1 M0 T3 N0, N1 M0 Stage IVA T1, T2, T3 N2 M0 T4a N0, N1, N2 M0 Stage IVB T4b Any N M0 Any T N3 M0 Stage IVC Any T Any N M1

Page 9: Max Sinus tumours

TUMORS Intrinsic origin Squamous papilloma Inverted papilloma Juvenile angiofibroma Vascular lesions Myxoma Giant cell tumor

Extrinsic origin Ameloblastoma OAT Odontoma Odontogenic myxoma

TUMOR-LIKE LESIONS:Giant cell granuloma

Fibrous dysplasia

Page 10: Max Sinus tumours

MALIGNANT LESIONS

Squamous cell carcinoma

Adenoid cystic carcinoma

Adenocarcinoma

Sarcoma (Chondrosarcoma, Osteosarcoma, Fibrosarcoma)

Non-Hodgkin’s lymphoma

Page 11: Max Sinus tumours

Ohngren lines

Page 12: Max Sinus tumours
Page 13: Max Sinus tumours

Polyp Nonneoplastic

epithelial & stroma tumours

Types: Inflammatory polyp Antrochoanal polyp

Page 14: Max Sinus tumours

Papilloma Benign tumor of nasal

cavity composed of vascular connective tissue covered by well-differentiated stratified squamous epithelium that tends to grow under and elevate mucosa.

Page 15: Max Sinus tumours

Pathogenesis

— allergy, chronic inflammation — human papilloma virus (HPV)

Page 16: Max Sinus tumours

Clinical Features Most common in males aged 40–70 years Nasal stuffiness or obstruction. Secondary bacterial sinusitis. Postoperative recurrence 35–40%. May be associated with malignancy (about

10%).

Page 17: Max Sinus tumours

Types (Batsakis)1) Keratotic papilloma simple cutaneous wart, exophytic with

broad base, in the nasal vestibule or nasal septum.

2) Inverted papilloma-lateral nasal wall

3)Fungiform (50%) - septum4)Cylindrical (3%) - lateral nasal wall

Page 18: Max Sinus tumours

Inverted papilloma Arises from respiratory

mucosa of sinonasal tract

Involves lateral nasal wall & extends to adjacent maxillary sinus

Bulky, deep red, gray colour

Age>40ys , high morbidity: 50—60ys;

M: F=3:1

Page 19: Max Sinus tumours

Site of occurance: junction of antrum & ethmoid sinus

Unilateral nasal obstruction, congestion, epistaxis, abnormalities of smell.

Page 20: Max Sinus tumours

HistopathologyHyperplastic epithelia

with inverting pattern of growth. Epithelial inversion into underlying stroma. Basal membrane is intact.

Page 21: Max Sinus tumours

Fungiform papillomas an exophytic growth pattern and do not

grow down into the underlying normal stroma. They are almost always associated with human papillomavirus, and unlike inverted papillomas, do not have a tendency to recur.

Page 22: Max Sinus tumours

Cylindrical cell papillomas They have a ragged, beefy appearance

and histologically they appear totally different. They are composed of columnar cells. They have a pink cytoplasm, their nuclei are oval or round,

Page 23: Max Sinus tumours

Axial CT

Page 24: Max Sinus tumours

Juvenile angiofibroma Highly vascular lesion, locally invasive, non encapsulated Age-10-17 years Site: posterior nares & nasopharyx Etiology:Popular theories include abnormal growth of

embryonal chondrocartilage, testosterone acting on a hamartomatous nidus of inferior turbinate tissue mislocated in the nasopharynx, tumor growth from normal nasopharyngeal fibrovascular stroma- may be due to androgen receptors capable of binding dihydrotestosterone & testosterone may indicate hormonal influence

trauma, inflammation, infection, allergy, and heredity.

Page 25: Max Sinus tumours

Clinical features Site: posterolateral wall of the nasal cavity at

posterior nares & nasopharynx From its origin, tumor spreads into the nasal

cavity and nasopharynx- displacing the soft palate inferiorly, Anteriorly, it pushes forward the posterior wall of the maxillary sinus, creating the classic "antral bowing sign" visible by x-ray.

Posteriorly, it disrupts the root of the pterygoid plates. Superiorly, tumor expands into the orbit via the inferior orbital fissure, continuing eventually into the superior orbital fissure and middle cranial fossa.

Page 26: Max Sinus tumours

With further lateral expansion, the tumor will pass through the pterygomaxillary fissure into the infratemporal fossa, often creating a bulging of the cheek. If it reaches the temporal fossa, the tumor can create a bulge above the zygoma.

lobulated, firm, non-encapsulated mass, usually pink-gray or purple-red. The tumor base may be sessile or pedunculated.

Page 27: Max Sinus tumours

The most common presenting symptoms are nasal obstruction, epistaxis, diplopia, blindness, hearing loss, otitis media, rhinorrhea, nasal speech, noisy sleep, mouth breathing, eye pain, and headache.

Page 28: Max Sinus tumours

histopathology CT- cleft like vascular

vascular channels Cellular atypia

Page 29: Max Sinus tumours

Ameloblastoma Secondary to direct extension from

maxillary alveolar ridge Misplaced dental analage from epithelial

lining of dentigerous cyst c/f:asymptomatic swelling of cheek and

mucobuccal fold On penetration it enlarges & fills the antral

space Proptosis, nasal obstruction due to

involvment of superior & lateral nasal wall.

Page 30: Max Sinus tumours

R/F

Page 31: Max Sinus tumours

odontoma End products of anomalous anomalous

completion or lack of completion of tooth formation by odontogenic epithelium & ectomesenchyme

Complex Compound c/f- nasal obstruction, discharge, sinusitis

Page 32: Max Sinus tumours

R/F

Page 33: Max Sinus tumours

Odontogenic myxoma Site- maxillary bone, antral mucosa slow-growing, persistent and destructive,

may cross midline Gross feature: slimy, pale yellow mucoid

substance. Consistency is soft to moderate firm. Poorly circumscribed & infiltrates to surrounding tissues

Page 34: Max Sinus tumours

R/F

unilocular/multilocular radioluscency with honeycomb or soap bubble appearance

Page 35: Max Sinus tumours

H/F Loosely arranged

fibroblast and myofibroblast.

Cells are stellate with long protoplasmic process

Page 36: Max Sinus tumours

Fibrous dysplasia Site: posterior maxilla C/F: rapid growth and enlargement of jaw

with facial deformity, Painless swelling

Page 37: Max Sinus tumours

R/F

Page 38: Max Sinus tumours

3D CT

Page 39: Max Sinus tumours

Ossifying fibroma C/F: nasal obstruction, proptosis, malar

enlargement, vestibular swelling R/F: expansion, margination, demarcation,

cortication, displacement of teeth

Page 40: Max Sinus tumours

Malignant tumorsMetaplastic type of epithelium- squamous

cell groupGlandular cell type epithelium-

adenocarcinoma group.

Page 41: Max Sinus tumours

Squamous cell carcinoma A malignant epithelial neoplasm

originating from the mucosal epithelium of the nasal cavities or paranasal sinuses that includes a keratinizing and a non-keratinizing type.

Page 42: Max Sinus tumours

Etiology Reported risk factors have include

exposure to nickel, chlorophenols, and textile dust, smoking, and a history or concurrence of sinonasal papilloma.

Page 43: Max Sinus tumours

Clinical features More than 60% originate in maxillary sinuses,

followed by nasal cavity, and ethmoid sinuses nasal fullness, stuffiness, or obstruction;

epistaxis; rhinorrhea; pain; paraesthesia; fullness or swelling of the

nose or cheek or a palatal bulge; a persistent or non-healing nasal sore or ulcer; nasal mass;

In advanced cases, proptosis, diplopia, or lacrimation

Page 44: Max Sinus tumours

Macroscopy exophytic, fungating,

or papillary; friable, haemorrhagic, partially necrotic, or indurated; demarcated or infiltrative.

Page 45: Max Sinus tumours

R/F

Page 46: Max Sinus tumours

R/F

Destruction of LT maxilla Intrasinus mass with irregular

destruction

Page 47: Max Sinus tumours

Coronal CT

Intrasinus mass with irregular destruction of alveolus MRI- intrasinus & intraoral mass

Page 48: Max Sinus tumours

H/F extracellulr or intracellular

keratin (pink cytoplasm, dyskeratotic cells) and/or intercellular bridges. Tumour cells are generally apposed to one another in a “mosaic tile” arrangement.

The tumour may be arranged in nests, masses, or as small groups of cells or individual cells.

Invasion occurs as blunt projections or ragged, irregular strands. carcinomas may be well, moderately, or

poorly differentiated

Page 49: Max Sinus tumours

Adenoid cystic carcinoma Adenoid cystic carcinoma is the most

frequent malignant salivary gland-type tumour of the sinonasal tract.

Age-11-92 years. C/F: nasal obstruction, epistaxis, pain,

paraesthesia, displacement of orbital content, swelling of the palate or face, loosening of the teeth.

Evidence of perineural & intraneural spread

Page 50: Max Sinus tumours

R/F CT scan shows a nasal

sinus mass focally extending into the bone.

Page 51: Max Sinus tumours

H/F An intact surface

mucosa overlying the cribriform and cystic patterns

Page 52: Max Sinus tumours

Common route of distant metastasis Lung, bone, liver, brain

Page 53: Max Sinus tumours

adenocarcinoma glandular malignancies of the sinonasal tract. Etiology: wood dust and leather dust C/F: unilateral nasal obstruction, rhinorrhea and

epistaxis. Advanced tumours may cause pain, neurologic disturbances exophthalmos and visual disturbances.

Page 54: Max Sinus tumours

R/F

Page 55: Max Sinus tumours

H/F papillary growth

pattern and occasional tubular glands

Page 56: Max Sinus tumours

Non Hodgkin’s lymphoma Involve lymph nodes, lymphoid organs,

extranodal organs and tissues B lymphomas are found mostly in

maxillary sinus C/F: swelling which may ulcerate later,

pain.

Page 57: Max Sinus tumours

Staging of Maxillary Sinus Tumors T1: limited to antral mucosa without bony erosion T2: erosion or destruction of the infrastructure,

including the hard palate and/or middle meatus T3: Tumor invades: skin of cheek, posterior wall

of sinus, inferior or medial wall of orbit, anterior ethmoid sinus

T4: tumor invades orbital contents and/or: cribriform plate, post ethmoids or sphenoid, nasopharynx, soft palate, pterygopalatine or infratemporal fossa or base of skull

Page 58: Max Sinus tumours

TREATMENT OF NEOPLASM OF

MAXILLARY SINUS

Page 59: Max Sinus tumours

Surgery Unresectable tumors:

Superior extension: frontal lobes Lateral extension: cavernous sinus Posterior extension: prevertebral fascia Bilateral optic nerve involvement

Page 60: Max Sinus tumours

Surgery Surgical approaches:

Lateral rhinotomy Transoral/transpalatal Midfacial degloving Weber-Fergusson Combined craniofacial approach

Extent of resection Medial maxillectomy Inferior maxillectomy Total maxillectomy

Page 61: Max Sinus tumours

Culd wel luc procedure Indications: Mucoceles Antrochoanal polyp OKC

Page 62: Max Sinus tumours
Page 63: Max Sinus tumours

Transpalatal approach Indications: Small tumors of inferior and posterior

aspect

Page 64: Max Sinus tumours
Page 65: Max Sinus tumours

Lateral Rhinotomy & medial maxillectomy Indications: Well differentiated or low grade tumour Ameloblastoma Inverted papilloma

Page 66: Max Sinus tumours
Page 67: Max Sinus tumours

Medial maxillectomy A. access ostectom B. Removal of septum

to gain contralateral access

C.More lateral extension to gain access to ethmoids

D.Bone cuts to gain access to antrum

Page 68: Max Sinus tumours

Webwr fergusson approach OKC, myxoma, Ameloblastoma, CEOT

Page 69: Max Sinus tumours
Page 70: Max Sinus tumours

Midfacial degloving

Page 71: Max Sinus tumours

Chemotherapy Palliation, unresectable disease (+) margins, perineural spread, surgical

refusal, ECS Robbins - 86% response of T4 lesions Lee - 91% satisfactory response Agents: 5FU(1000mg/m2),

Cisplatinum(150mg/m2/wk/4wk)

Page 72: Max Sinus tumours

Radiation therapy

Primary tx only for palliation 10-15% improved 5 year survival XRT = 23% vs. Surgery + XRT = 44% 68-72 Gy

Page 73: Max Sinus tumours

Reconstruction Split thickness skin graft with obturator Soft tissue flaps and bone graft

Page 74: Max Sinus tumours

MAXILLECTOMYSurgical removal of maxilla

Page 75: Max Sinus tumours

Classification of maxillectomy

Page 76: Max Sinus tumours

Type 1 defects (limited maxillectomy) Type 2 defects (subtotal maxillectomy). Type 3 (total maxillectomy) which is

subdivided into type 3a (orbital content preservation) and type 3b (orbital content exenteration).

Type 4 defects (orbitomaxillectomy)

According to Cordeiro and Sanatamaria

Page 77: Max Sinus tumours

Maxillectomy classification scheme according to Okay et al. Class 1a includes defects of any

portion of the hard palate excluding tooth bearing maxillary alveolus.

Class 1b includes defects of premaxilla or any portion of alveolus or dentition posterior to canines.

Class 2 defects include any portion of hard palate, alveolus and only one canine tooth. Also includes transverse palatectomy involving less than 50% of the hard palate.

Class 3 defects include resection of any portion of hard palate, alveolus and both canine teeth. Also includes transverse palatectomy involving greater than 50% of the hard palate.

Page 78: Max Sinus tumours

Subtotal maxillectomy Indications: Lesions of palate,

antrum, beyond the confines of antrum

Page 79: Max Sinus tumours
Page 80: Max Sinus tumours

Medial maxillectomy Indications:well

differentiated/low grade malignant tumour, inverted papilloma, or other tumors of limited extent to lateral wall of nasal cavity or medial wall of antrum

Page 81: Max Sinus tumours
Page 82: Max Sinus tumours

Total maxillectomy Indications: Primary tumour

arising from surface lining of maxillary antrum fills the entire antrum.

Page 83: Max Sinus tumours
Page 84: Max Sinus tumours

Treatment of the Orbit Before 1970’s orbital exenteration was

included in the radical resection Preoperative radiation reduced tumor load

and allowed for orbital preservation with clear surgical margins

Currently, the debate is centered on what “degree” of orbital invasion is allowed.

Page 85: Max Sinus tumours

Current indications for orbital exenteration Involvement of the orbital apex Involvement of the extraocular muscles Involvement of the bulbar conjunctiva or

sclera Lid involvement beyond a reasonable hope

for reconstruction Non-resectable full thickness invasion

through the periorbita into the retrobulbar fat

Page 86: Max Sinus tumours

Classification and Concepts in Reconstruction

Page 87: Max Sinus tumours

Flaps used in maxillary reconstruction Palatal mucoperiosteal island flap Buccal fat pad Submental island flap Temporalis flap system Radial forearm flap Fibula flap Scapular flap system Iliac crest flap Abdominal rectus flap

Page 88: Max Sinus tumours

A Class 1 defect can be simply treated with obturation or a soft tissue flap often preferred at the junction of the hard and soft palate.

Pedicled flaps:iliac crest maintained in a titanium mesh structure, the buccal fat pad, submental island flap

Free tissue transfer: composite fibula flap, Radial forearm flap

Page 89: Max Sinus tumours

Class 2b-c fibula flap iliac crest Class 3a-c iliac crest with internal oblique titanium mesh or free bone from the hip Class 4a iliac crest with internal oblique, Rectus,

Lattisimus dorsi

Page 90: Max Sinus tumours

Radial Forearm Flap 1978 (China) by Yang etal, 1985 (pharyngeal

recon) Oral cavity, base of tongue, pharynx, soft palate,

cutaneous defects, base of skull, small volume bone and soft tissue defects of face

Thin, pliable skin Reconstitution of contours, sulci, vestibules

Fasciocutaneous flaps are highly tolerant of radiation therapy

Composite flap with bone, tendon, brachioradialis muscle and vascularized nerve.

Page 91: Max Sinus tumours

Neurovascular pedicle Up to 20 cm long Vessel caliber 2 – 2.5 mm Radial artery cephalic vein Lateral antebrachial

cutaneous nerve (sensory)

Page 92: Max Sinus tumours

Technical considerations Tourniquet

Flap designed with skin paddle centered over the radial artery

Dissection in subfascial level as the pedicle is approached.

Pedicle identified b/w medial head of the brachioradialis, and the flexor carpi radialis

Radial artery is dissected to its origin

External skin monitor can be incorporated into the flap (proximal segment)

Page 93: Max Sinus tumours

Radial Forearm Flap

Page 94: Max Sinus tumours

Radial Forearm Flap Morbidity

Hand ischemia Fistula rates - 42% to 67% in early series Radial nerve injury Variable anesthesia over dorsum of hand.

Advantage:Thin pliable skin, often hairless,long pedicle(12-

15cm),Disadvantage:Donor site defect visible

Page 95: Max Sinus tumours

Fibular free flap 1975 Hidalgo – mandibular recon

1989 Longest possible segment of

revasularized bone (25 cm) Ideal for osseointegrated

implant placement Mandible reconstruction (near

total), maxillary reconstruction

Page 96: Max Sinus tumours

Neurovascular pedicle Peroneal artery and vein Sensate restoration with lateral sural

cutaneous nerve Peroneal communicating branch

vascularized nerve graft for lower lip sensation

Skin perforators Posterior intermuscular septum

(septocutaneous or musculocutaneous through flexor hallucis longus and soleus)

Should always include cuff of flexor hallucis longus and soleus in flap harvest

5-10% of cases blood supply to skin paddle is inadequate

Page 97: Max Sinus tumours

Technical considerations Choose leg based on ease

of insetting Intraoral skin paddle

Harvest flap from contralateral side of recipient vessels

8 cm segment preserved proximally and distally to protect common peroneal nerve and ensure ankle stability

Center flap over posterior intermuscular septum Anterior to soleus and

posterior to peroneus

Page 98: Max Sinus tumours

Fibular free flap Morbidity

Donor site complications Edema Weakness in dorsiflexion of great toe

Skin loss in 5 – 10% of flaps

Page 99: Max Sinus tumours

Submental artery island flap

Thin, supple skin Submental branch of

facial artery Primary closure of

donor site Poor reliability if:

Facial artery sacrificed Irradiated neck Adv: Large flap size (7-15

cm) Superior skin color

match

Page 100: Max Sinus tumours

disadvantage Not suitable if patient has previous level 1

nodal disease

Page 101: Max Sinus tumours

Temperoparietal Fascia Flap Described by Golovine More commonly transferred as a pedicled flap but can be

used as a free flap when arc of rotation is inadequate Ultra thin – 2 to 4 mm thick Highly vascular, pliable and durable Fascial, fasciocutaneous

Page 102: Max Sinus tumours

Neurovascular pedicle Superficial temporal artery and vein – travel in TPF

layer 3 cm superior to root of helix Vessels branch into frontal and temporal divisions Most commonly based on parietal branch Ligation of frontal artery 3 – 4 cm distal to branching

point to avoid frontal nerve injury Venous pedicle may course with arteries or 2 to 3 cm

posteriorly Middle temporal artery – proximal superficial

temporal artery at zygomatic arch (supplies temporalis muscular fascia)

Including middle temporal artery enables a two-layered fascial flap on a single pedicle.

Page 103: Max Sinus tumours

Temperoparietal Fascia Flap

Page 104: Max Sinus tumours

Technical considerations Vertical incision over

root of helix to superior temporal line

V-shaped extension at superior limit of incision

Scalp elevation ant and post

Dissect deep to flap Loose areolar tissue

deep to flap

Page 105: Max Sinus tumours

Temperoparietal Fascia Flap Morbidity

Frontal branch weakness (travels in TPF) Secondary alopecia – damage to hair follicles

due to superficial dissection

Page 106: Max Sinus tumours

Buccal fat pad A – branches of buccinator artery Rapid reepithelialization & only suitable for

medium sized defects up to 4cm Adv: Rapid reepithelialization Rich vascular supply No donor site skin scars

Page 107: Max Sinus tumours

Disadvantage: Only suitable for medium sized defects up

to 4cm Prone to dehiscence

Page 108: Max Sinus tumours

Iliac crest flaps Osteocutaneous, osteomusculocutaneous Up to 16 cm bone Oromandibular reconstruction Only vascularized bone used extensively with simultaneous or delayed

endosteal dental implant placement Skin paddle was not ideal for relining the oral cavity

Too thick for accurate restoration of the 3D anatomy

Page 109: Max Sinus tumours

Neurovascular pedicle

Deep circumflex iliac artery from lateral aspect of external iliac artery

1 – 2 cm cephalic to inguinal ligament

Ascending branch of deep circumflex iliac artery supplies internal oblique muscle

Deep circumflex iliac vein – Can pass either superficial to deep

to artery Artery caliber – 2 to 3 mm Vein caliber – 3 to 5 mm Pedicle to internal oblique can

arise separately from deep circumflex iliac artery

Page 110: Max Sinus tumours

Iliac crest flaps Morbidity

Hernia Need to approximate cut edge of iliacus muscle to

transversus abdominis Can be reinforced by drilling holes into cut edge of iliac

bone Approximate external obliques and aponeurosis to tensor

fascia lata and gluteus muscles Keep inferior oblique inferior and anterior to ASIS

Skin loss from perforator sheer injury poor color match

Page 111: Max Sinus tumours

Rectus abdominis Easy to harvest Long pedicle(10cm) Skin from abdomen and lower chest Myocutaneous flap or muscle only flap Not used for functional motor reconstruction Can include entire muscle or only small portion in

paraumbilical region Plentiful people – thinner flap created by skin grafting the

muscle Skinny people

Flap used for moderately volume defects Poor color match Tends to become ptotic Able to fill large tissue deficits

Page 112: Max Sinus tumours

Neurovascular pedicle Two dominant pedicles

Deep superior epigastric artery/vein Deep inferior epigastric artery and

vein Based on inferior epigastrics when

used for h/n recon because of larger pedicle size

Inferior epigastric diameter – 3 to 4 mm

Reinnervated with any of the lower six intercostal nerves.

Pedicle may travel along lateral aspect of muscle before taking intramuscular route

Page 113: Max Sinus tumours

Scapular flaps Fasciocutaneous, osteofasciocutaneous,

cutaneous flap, parascapular cutaneous flap, latissimus dorsi myocutaneous flap, and serratus anterior flap

Thin, hairless skin Two cutaneous flaps may be harvested

Horizontally oriented flap – transverse cutaneous branch

Vertically oriented flap parascapular flap – descending cutaneous branch

Long pedicle length Large surface area Complex composite midfacial or

oromandibular defects Up to 10 cm bone Osseointegrated implants possible Single team approach

Page 114: Max Sinus tumours

Neurovascular pedicle Subscapular artery and vein

Circumflex scapular artery and vein emerge from triangular space (teres major, teres minor and long head of triceps)

Paired venae comitantes Artery caliber – 4 mm at takeoff from subscapular

Subscapular caliber – 6 mm at takeoff from axillary artery

Pedicle length – 7 to 10 cm, 11 to 14 cm (from axillary artery)

Largest amount of tissue available for transfer

Page 115: Max Sinus tumours

Technical considerations Decubitis positioning

15 degree angle Separate axillary incision

helpful in dissecting pedicle to axillary artery and vein

Bone harvest Teres major, subscapularis

and latissimus dorsi need to be reattached to scapula

Flap harvest opposite side of modified or radical neck dissection

Page 116: Max Sinus tumours

Scapular flaps Morbidity

Brachial plexus injury 2/2 lateral decubitis positioning

Use axillary roll Stay 1 cm inferior to glenoid fossa Detach teres major and minor to harvest bone

Can cause shoulder weakness and limit range of motion.

Page 117: Max Sinus tumours

Scapular flaps Preoperative

Considerations Prior axillary node

dissection – contraindication

Postoperative management Immobilize for 3 to 4

days Early ambulation 5 days for bone harvest PT

Page 118: Max Sinus tumours

This long implant is anchored in the upper jawbone and in the very dense zygoma bone. A temporary prosthesis can be fixed immediately after placing the implant and until the final restoration, once the aesthetic criteria have been met and your expectations have been fulfilled

Zygomatic implants

Page 119: Max Sinus tumours

obturator